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Prevalence of simple liver cysts and hemangiomas
in cirrhotic and non-cirrhotic patients submitted to magnetic
resonance imaging*
Prevalência de cistos simples e hemangiomas hepáticos em pacientes cirróticos e não cirróticos submetidos
a exames de ressonância magnética
Breno Victor Tomaz Galvão1, Lucas Rios Torres2, Patrícia Prando Cardia2, Thiago Franchi Nunes2,
Priscila Silveira Salvadori1, Giuseppe D’Ippolito3
Objective: To determine the prevalence of liver cysts and hemangiomas in the general population and in cirrhotic patients.
Materials and Methods: Retrospective, observational, and cross-sectional study selecting consecutive magnetic
resonance imaging studies performed in the period from February to July 2011. A total of 303 patients (187 women and
116 men) with mean age of 53.3 years were included in the present study. Patients with previously known liver lesions
were excluded. The images were consensually analyzed by two observers in the search for simple liver cysts and typical
liver hemangiomas, according to universally accepted imaging criteria. Lesions prevalence, diameters and location were
determined in both cirrhotic and non-cirrhotic individuals. Results: The authors observed prevalence of 8.6% for
hemangiomas and 14.5% for simple cysts. No statistically significant difference was observed in relation to prevalence
of hemangiomas and cysts among cirrhotic and non-cirrhotic patients (p = 0.954; p = 0.472). Conclusion: In the present
study, the prevalence of cysts and hemangiomas was higher than the prevalence reported by autopsy series. No influence
of cirrhosis was observed on the prevalence and appearance of such incidental lesions.
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Objetivo: Determinar a prevalência de cistos e hemangiomas hepáticos na população geral e em pacientes cirróticos.
Materiais e Métodos: Estudo retrospectivo, observacional e transversal selecionando exames consecutivos de resso-
nância magnética de abdome realizados entre fevereiro e julho de 2011. Foram incluídos 303 pacientes (187 mulheres
e 116 homens) com idade média de 53,3 anos, excluindo-se os com lesão hepática previamente conhecida. Os exa-
mes foram lidos por dois examinadores em consenso, procurando caracterizar cistos hepáticos simples e hemangiomas
típicos segundo critérios de imagem universalmente aceitos. Foram medidos a prevalência das lesões, seus diâmetros
e localização em pacientes com e sem cirrose hepática. Resultados: Encontrou-se prevalência de 8,6% para heman-
giomas e 14,5% para cistos simples. Não houve diferenças estatisticamente significativas nas prevalências de heman-
giomas e cistos entre pacientes cirróticos e não cirróticos (p = 0,954; p = 0,472). Conclusão: As prevalências encon-
tradas de cistos e hemangiomas foram mais altas que as das séries de autópsias. Não houve influência da presença de
cirrose na prevalência e aspecto dessas lesões incidentais.
Unitermos: Hemangioma; Cistos; Ressonância magnética; Prevalência; Fígado.
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ORIGINAL ARTICLE
signs and symptoms presented by the pa-
tient(1).
Because of its frequency, special atten-
tion has been paid to such type of lesion in
the literature, leading medical societies to
develop consensus and treatment and fol-
low-up protocols(2).
As regards liver incidentalomas, cysts
and hemangiomas are most frequently
found. Although in most cases the diagno-
sis of such lesions, as well as the determi-
nation of their benign nature by means of
the available imaging methods are per-
INTRODUCTION
The number of magnetic resonance im-
aging (MRI) studies has increased over the
past few years, both because of the wider
availability of the method and because of
the increase in the number of applications
in different clinical settings. Such phenom-
enon contributes to the increased detection
of incidental focal liver lesions (FLLs), also
called incidentalomas. The term “inci-
dentaloma” is reserved to the type of lesion
not related to the clinical suspicion or to the
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formed with no major difficulties, their
prevalence at imaging studies in the general
population is still to be accurately esti-
mated. The references utilized in most stud-
ies on the theme rely on autopsy studies or
surgical series including quite divergent
data, ranging from 0.4% to 20% for heman-
giomas and from 1% to 14% for simple
cysts, with such data sometimes having
been acquired several decades ago(3–5).
Furthermore, the increase in the number
of cirrhotic   patients, either for viral or
toxic causes, has led to the increase in the
number of screening investigations(6). For
these patients, the differentiation between
benign and malignant lesions is crucial to
determine the therapeutic approach. For
that reason, a system for the characteriza-
tion of hepatic lesions, called LI-RADS®,
was recently developed(7).
Some recent studies have attempted to
establish the frequency of pancreatic cysts
incidentally found at MRI(8), but there is a
necessity of similar studies approaching the
detection of FLLs.
A theme that has been widely discussed
in the literature, generating some contro-
versy is related to the frequency of heman-
giomas in cirrhotic livers, which would be
lower than that in the general population(9–
11)
. MRI is considered to be a highly sensi-
tive and specific method for the diagnosis
of hepatic cysts and hemangiomas(9). The
possibility of acquiring images in different
planes, the high contrast between soft tis-
sue structures and the analysis of the vas-
cular behavior of lesions and surrounding
organs potentialize its utilization as a diag-
nostic tool optimized with the adoption of
new techniques and sequences(12–15), thus
improving the capability of the method to
detect and characterize focal lesions. For
these reasons, the prevalence of FLLs iden-
tified at MRI could be higher than the pre-
viously observed prevalence.
Based on such considerations, the
present study was proposed in order to pro-
vide updated data on the frequency of cysts
and hemangiomas incidentally found at
MRI both on cirrhotic and non-cirrhotic pa-
tients.
MATERIALAS AND METHODS
Population
A retrospective, cross-sectional and ob-
servational study was undertaken by
means of survey on the digital Picture
Archiving and Communication System –
PACS (Synapse®; FujiFilm, USA) of all
patients who had undergone upper abdo-
men MRI in the period between February
1st, and July 10, 2011, comprising a total
of 363 patients. Exclusion criteria were the
following: patients under the age of 18,
indication for investigation of hepatic nod-
ules in non-oncologic cases, images con-
sidered technically unsatisfactory, and
images acquired under directed protocols
which did not comprise the whole liver
parenchyma (adrenal and MRI urography,
for example). The final study sample in-
cluded 303 patients (187 women and 116
men), with mean age of 53.3 years (± 16.5
years), 57 of them with cirrhosis. The pa-
tients were considered cirrhotic in the pres-
ence of a combination of clinical/labora-
tory findings (for example: esophageal
varices, splenomegaly, thrombocytopenia,
increased bilirubin and liver enzymes lev-
els), with imaging findings (37 patients),
or with percutaneous biopsy findings (20
patients).
The patients’ clinical data were col-
lected from the digital records system of the
institution, comprising information on vis-
its, previous imaging studies, laboratory
tests results and surgical data, if available.
The clinical indications for the reviewed
studies varied, with the most common be-
ing evaluation of obstructive bile duct dis-
eases and cancer staging.
The application of a term of free and in-
formed consent was waived, according in-
structions and approval by the Committee
for Ethics in Research of the institution
(CEP 1067/11).
Imaging technique
All patients were submitted to upper ab-
domen MRI according the institution’s
standard protocol, in an Magnetom Sonata
Maestro Class® equipment operating with
a 1.5 tesla high magnetic field (Siemens;
Erlangen, Germany), with synergy coil and
with breath hold technique.
T1-weighted in-phase and out-phase,
gradient-echo sequences were acquired as
follows: single shot fast spin echo
(HASTE®); steady state fast field echo
(TRUFI®); and 3D turbo field echo fat-sat
(VIBE®), before and after contrast medium
injection (0.5 mmol/ml gadoteric acid –
Dotarem®, Guerbet), on arterial, portal and
equilibrium phases (respectively 30, 60 and
180 seconds after the intravenous contrast
medium injection) at an infusion rate of 2.0
ml/s and dose of 0.2 ml/kg. The technical
parameters of the sequences are repre-
sented on Table 1.
Images interpretation
The acquired images were available for
visualization on a digital workstation (Syn-
apse®; FujiFilm, USA), where they were
consensually evaluated by two radiologists,
among the five radiologists who comprised
the observers team, with experience in ra-
diology ranging from 2 to 20 years. In the
Table 1 Technical parameters of upper abdomen magnetic resonance imaging.
Sequence
T1 in/out phase
Single shot fast spin echo*
Single shot fast spin echo
Steady state fast field echo*
3D turbo field echo fat-sat†
Commercial
name
HASTE
HASTE
TRUFI
VIBE
Slice
plane
Axial
Axial
Coronal
Coronal
Axial
Slice thickness
(mm)
5.0
5.0
5.0
5.0
2.5
Matrix
256 × 179
256 × 179
256 × 179
256 × 179
256 × 179
FOV (mm)
350–400
350–400
350–400
350–400
350–400
Gap
10%
10%
0
0
0
Flip angle
(°)
70
180
180
75
30
Band
(Hz/pxl)
380
390
390
500
320
NA
1
1
1
1
1
AT (s)
24
29/36
27
19/21
TR (ms)
132
900
900
4.3
4,66
6900
TE (ms)
2.3/4.7
86
86
2.15
2.15
86
* Sequences with and without fat saturation. † Non-contrast-enhanced, arterial, portal and equilibrium phases. FOV, field-of-view; NA, number of acquisitions; AT, acquisition
time; TR, repetition time; TE, echo time.
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cases where more than one study from a
single patient was available over the stud-
ied period, only the most recent one was
considered.
The observers actively sought for liver
hemangiomas and simple hepatic cysts
with characteristic features, as widely de-
scribed in the literature(8–10). Thus, heman-
giomas were those nodules with hyper-
signal on T2-weighted images with long
echo time (TE > 130 ms) and with globuli-
form, discontinuous, progressive and cen-
tripetal enhancement (progressive type) or
with fast, early and persistent enhancement
(flash-filling type)(9,10), and simple cysts,
those homogeneous nodules hypointense
on T1-weighted and hyperintense on T2-
weighted, with a thin capsule, without
septa, vegetations or enhancement areas
after intravenous paramagnetic contrast
medium injection(8). Focal lesions of unde-
termined nature or of other natures were not
taken into consideration. The measurement
of the largest axial diameter of the lesion
was made on the sequence with highest
conspicuity. The number and location of
lesions were defined, as well as the en-
hancement pattern for the hemangiomas
(progressive or flash-filling) (Figures 1 and
2)(10). In cases of more than five lesions in
a single patient, only the largest five lesions
were considered. Patients with innumerable
small cysts (< 1.5 cm) widely disseminated
throughout the parenchyma and with ap-
pearance suggestive of biliary hamartomas,
were not included in the study sample.
The liver lesions were characterized ac-
cording to their imaging features as simple
cysts, typical hemangiomas and solid nod-
ules, including in the latter group any lesion
which did not meet the criteria for the two
first groups. The cysts which were consid-
ered atypical(16) were not included in any of
the groups. Additionally, those patients
with cirrhotic liver features were also cat-
egorized following the criteria widely
adopted in literature(6,17).
Statistical analysis
The associations between qualitative
variables (gender, type of hemangioma en-
hancement and presence or absence of liver
cirrhosis) were made by means of the chi-
squared test (χ2). For the quantitative vari-
ables (patients’ age and lesion dimensions)
parametric tests were utilized whenever
normal distribution was observed, and non-
parametric tests whenever normal distribu-
tion was not observed.
The comparison of quantitative vari-
ables between the several groups was made
by means of the t test in the case of two
groups, or by variance analysis in the case
Figure 2. Hepatic heman-
gioma with flash-filling en-
hancement pattern.
of more than two groups. In the case of sig-
nificant variance analysis, a multiple com-
parisons test was subsequently applied
(Turkey’s test).
The adopted significance level was 5%
and the statistical tests were carried out by
means of the SPSS 11.0 software.
RESULTS
Hepatic cysts
Among all individuals, 44 had 95 he-
patic cysts, making up a prevalence of
14.5% in the studied population (in 10 cir-
rhotic and 34 non-cirrhotic patients). Out
the total of 44 patients with cysts, 23 pre-
Figure 1. Hepatic hemangioma with progressive enhancement pattern.
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sented single cysts, while 21 patients pre-
sented multiple cysts. The most commonly
affected hepatic segments were the IVa
(23%) and VI (17%) segments. The mean
cyst size was 1.0 cm (ranging from 0.2 cm
to 8.8 cm). Out the total of 95 cysts, 66 were
< 1.0 cm.
As the prevalence of simple hepatic
cysts in the cirrhotic population was deter-
mined (10/57; 17.5%) and compared with
the prevalence in the non-cirrhotic popula-
tion (34/246; 13.8%) no statistically signifi-
cant difference was observed (p = 0.472).
The dimensions and distribution of the
cysts in these two populations did not
present any statistically significant differ-
ence either. No difference was observed in
the prevalence of hepatic cysts with respect
to gender and age.
Hemangiomas
In the present study, 47 hemangiomas
were detected in 26 patients (prevalence of
8.6%), 7 of them cirrhotic, while 19 were
non-cirrhotic. Out of the total of 26 patients
with hemangiomas, 17 had single heman-
giomas, while 9 had multiple hemangio-
mas. The most commonly affected hepatic
segments were the VI segment (21%) and
II segment (19%), and the mean diameter
of the hemangiomas was 2.13 cm (ranging
from 0.4 cm to 13.5 cm), with no statisti-
cally significant difference between the
group of cirrhotic patients (2.51 cm) and
the non-cirrhotic group (2.05 cm).
The most common enhancement pat-
tern was the progressive type, with a fre-
quency of 89.4%, and the flash-filling pat-
tern was observed in only 10.6% of the he-
mangiomas in the sample. In only two pa-
tients out of the total of 26 patients with
hemangiomas, the coexistence of two en-
hancement patterns was observed (one
patient had two hemangiomas, one of each
type, and the other had five hemangiomas,
with only one with the flash-filling en-
hancement pattern.
No statistically significant difference
was observed in the prevalence of hepatic
hemangiomas among cirrhotic (5/57; 8.8%)
and non-cirrhotic patients (21/246; 8.5%),
with p = 0.954. The same was observed for
the dimensions, distribution and enhance-
ment pattern of such lesions. Patients’ age
and gender did not influence the prevalence
of hepatic hemangiomas in the study
sample, i.e., the presence or absence of
hemangiomas was not associated with pa-
tients’ gender (χ2 = 0.695; p = 0.659; non-
significant), occurring in 8% of the women
and in 9.5% of the men. Mean sizes of the
hemangiomas in women and in men were,
respectively, 2.29 cm and 1.75 cm.
DISCUSSION
Cysts and hemangiomas are the most
common benign focal hepatic lesions(18).
Simple hepatic cysts may be either con-
genital or acquired and are related to devel-
opmental anomalies and/or conformation
of the biliary tree(19). Abdominal traumas
determining bile extravasation outside of
the biliary tree have been regarded as a
plausible cause of hepatic cysts(20). At MRI,
the cysts are seen as well-defined lesions
with hypersignal on T2-weighted se-
quences and hyposignal on T1-weighted
sequences. Depending upon the presence
of hemorrhage, there may be variation in
signal intensity. No enhancement is ob-
served after paramagnetic contrast medium
injection(16).
Reports in the literature indicate that the
prevalence and number of cysts increase
with age because of obstruction and biliary
stasis in small biliary ducts(21). An Austra-
lian study evaluating obstetric ultrasonog-
raphy images over a period of more than 10
years has found only three hepatic cysts in
fetuses(22). There is a reported predomi-
nance in female individuals, with a ratio
ranging between 1.5:1 and 5.5:1(23). The
data in the present study, however, do not
demonstrate any relationship between age
or gender and the occurrence of cysts.
The first reports on prevalence of simple
hepatic cysts were observed in autopsy
studies. In a series of 20,000 autopsies, a
prevalence of 0.14% (28 cysts)(24) was
found. Other similar studies have reported
values of 0.17% and 0.53%(25,26). More re-
cent data derived from imaging studies re-
veal slightly higher values. In 1989, an
European study about the prevalence at
ultrasonography recorded a prevalence of
2.5% (43 cases in a total of 1,695 pa-
tients)(27). Another study, in 1993, found
755 patients with hepatic cysts in a total of
26,000 sonographic images, corresponding
to a prevalence of 2.9%(28). On the other
hand, such prevalence may reach 5%-14%,
as demonstrated in at least one publica-
tion(29). A tomographic series developed in
2003 points out a simple hepatic cyst preva-
lence of 18% in 617 patients(30). More re-
cent studies focused on the therapeutic
approach for such lesions report values
ranging from 0.1% to 7%, frequently mak-
ing reference to decades-old data(31,32).
There is no report in the literature about the
prevalence of hepatic cysts found at MRI.
The results in the present study (14.5%)
demonstrate a higher prevalence than the
average found in previous studies, but simi-
lar to the prevalence in the studies which
relied on computed tomography(30), sup-
posedly related to the high detection capa-
bility of these diagnostic methods. Patients
with biliary hamartomas were not included
in the present study, as the authors under-
stand that such entities are different from
hepatic cysts(29). However, on the 363 MRI
studies initially evaluated, no case resem-
bling imaging findings suggestive of biliary
hamartomas was observed.
Hemangiomas correspond to vascular
spaces filled with slow flowing blood.
They present hypersignal at T2-weighted
sequences, which demonstrates to become
more conspicuous as the echo time of the
sequences increases, because of the de-
crease in signal from the surrounding he-
patic parenchyma(33,34). Three enhancement
patters can be observed after contrast agent
injection(34). The first pattern refers to le-
sions with intense enhancement at the ear-
lier phases, which remains unchanged at
delayed phases, and is called flash-filling.
The second pattern is the most common
one, and is characterized by peripheral,
discontinued and progressive enhance-
ment. The third pattern comprises the le-
sions with progressive enhancement, how-
ever with their center persistently without
enhancement. Like other authors(10), the
authors of the present study have opted for
grouping the second and third patterns into
a single group for the purpose of calcula-
tions. A clear predominance of the progres-
sive pattern over the flash-filling pattern
was observed (89.4% versus 10.6%). The
classical enhancement pattern associated
with its chronological stability has been
utilized as a reference standard in the de-
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termination of such diagnosis(10,35) and this
was the utilized strategy to define the typi-
cal hemangiomas found in the present
sample.
The references cited by authors who de-
scribe the prevalence of hemangiomas
commonly refer to decades-old studies ei-
ther with autopsy or surgical series. For
example, a 1999 study reported that in 508
hepatectomies in cirrhotic individuals only
9 hemangiomas were found, corresponding
to a prevalence of 1.7%(11). In 1997, another
study found a prevalence of 1.2% in a se-
ries of 596 autopsies(3). Higher values are
reported by a 1986 study(4), and like the
references cited by Semelka et al. in 1997
reach 20%(36). Finally, some studies still
rely on decades-old references, such as a
1958 North-American atlas, which points
out a prevalence of hemangiomas in 0.4%
of the individuals(37).
Although this is not a population study,
no previous attempts have been made to es-
tablish the prevalence of such lesions by
means of MRI. The wide variation in data
presented in the literature – from 0.4% to
20% for hemangiomas, and from 0.1% to
18% for simple cysts –, in association with
the attention that has been devoted to inci-
dental liver lesions have motivated the au-
thors to seek more updated data utilizing
modern and noninvasive diagnostic tools.
The results from the present study allow
the conclusion that the frequency of cysts
and hemangiomas found at MRI is high and
above that observed in autopsy studies,
perhaps because of the diligent survey for
such findings at MRI and because of the
facility in characterizing such type of le-
sion.
Because of vascular alterations ob-
served in cases of chronic liver disease, one
has suggested that, in such patients, there
might be differences in the presentation of
hepatic hemangiomas(10,38). Reports have
suggested that hemangiomas could degen-
erate and decrease in size as cirrhosis
progresses(11,39). On the other hand, at least
one study has demonstrated that size, num-
ber, location and enhancement pattern of
hemangiomas are not different in cirrhotic
patients(10). Similarly, in the present study,
no difference was observed in relation to
frequency or presentation of hemangiomas
in cirrhotic and non-cirrhotic livers.
Additionally, it was suggested that sup-
posed alterations of hemangiomas in cir-
rhotic patients might decrease their detect-
ability and, therefore, reduce their preva-
lence at imaging studies(9,11). The present
study results, however, contradict such a
possibility, demonstrating similar preva-
lence in both groups.
Although hemangiomas and hepatic
cysts are easily diagnosed and differenti-
ated from other liver lesions at ultrasonog-
raphy, computed tomography and MRI, it
is known that small hepatocarcinomas may
present homogeneous and early enhance-
ment similar to the flash-filling pattern
which may occur in some hemangio-
mas(40,41) and like in approximately 10% of
the present study sample.
The main limitation in the present study
lies in the inclusion criteria of the sample.
One can argue that the population referred
to a tertiary health center is not representa-
tive of the general population, for being
knowingly composed of unhealthy indi-
viduals, which might interfere in the veri-
fication of FLLs frequency. However, con-
sidering the lack of recent prevalence stud-
ies relying on diagnostic imaging methods,
the authors believe that the present study
brings a significant contribution to under-
standing the behavior of cysts and heman-
giomas. Future population studies will cer-
tainly clarify such questions.
Additionally, anatomopathological
studies were not utilized as a reference stan-
dard in the present study. However, the uti-
lization of imaging parameters for the di-
agnosis of cysts and hemangiomas is
widely diffused in the literature, thus elimi-
nating the necessity of utilizing the gold
standard, considering the questionable
cost-benefit ratio in utilizing invasive pro-
cedures instead, to obtain a diagnosis of
little prognostic repercussion for the pa-
tients under investigation. On the other
hand, the analysis of liver explants in cir-
rhotic patients might contribute for the es-
tablishment of the actual frequency of cysts
and hemangiomas in such group of pa-
tients. Finally, the diagnostic criteria uti-
lized for inclusion of patients in the cir-
rhotic group considered clinical/laboratory
parameters in a part of the sample (65%),
and anatomopathological study in the other
(35%) with less advanced stages of the dis-
ease, which, in a certain manner, reflects
the characteristics of the population as-
sisted in the authors’ institution.
CONCLUSIONS
In the present study the values for preva-
lence of cysts and hemangiomas are higher
than values reported by previously pub-
lished autopsy series, a fact which the au-
thors attribute to the high diagnostic capa-
bility of MRI for the described FLLs. Val-
ues that may be extrapolated to the general
population are still to be obtained by means
of population studies.
The prevalence and behavior of such
lesions in cirrhotic patients do not seem to
be different from that in the non-cirrhotic
population, contrary to what initial reports
suggested.
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